Neoplasm TransplantationLiver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationTransplantation ChimeraImmunosuppressive AgentsTreatment OutcomeTransplantation, IsogeneicGraft vs Host DiseaseLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationHeart-Lung TransplantationRetrospective StudiesNeoplasmsPancreatic NeoplasmsHematologic NeoplasmsTissue and Organ ProcurementTransplantation ToleranceTime FactorsPeripheral Blood Stem Cell TransplantationLiver FailureImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationPostoperative ComplicationsSkin TransplantationNeoplasms, Cystic, Mucinous, and SerousTransplantation, HeterologousRecurrenceWaiting ListsFollow-Up StudiesMesenchymal Stem Cell TransplantationCorneal TransplantationHistocompatibilitySurvival RateSurvival AnalysisTacrolimusTissue TransplantationLiver NeoplasmsWhole-Body IrradiationCyclosporineSkin NeoplasmsCadaverNeoplasms, Second PrimaryLeukemiaLiver DiseasesBrain Tissue TransplantationNeoplasms, Multiple PrimaryFacial TransplantationDonor SelectionOrgan PreservationImmunohistochemistryKidney NeoplasmsPrognosisCombined Modality TherapyBusulfanRisk FactorsTransplantsHLA AntigensLymphomaKidney Failure, ChronicMyeloproliferative DisordersBronchiolitis ObliteransFatal OutcomeBiopsyRemission InductionThyroid NeoplasmsAntilymphocyte SerumMice, Inbred C57BLAcute DiseaseAdenocarcinoma, MucinousHematopoietic Stem CellsPostoperative PeriodHand TransplantationAnemia, AplasticLiverCyclophosphamideBlood Group IncompatibilityCytomegalovirus InfectionsMycophenolic AcidLung NeoplasmsMyeloablative AgonistsDisease-Free Survival